Your browser is no longer supported. Please, upgrade your browser.
ATXS [NASD]
Astria Therapeutics, Inc.
Index- P/E- EPS (ttm)-54.23 Insider Own2.00% Shs Outstand12.83M Perf Week5.89%
Market Cap60.21M Forward P/E- EPS next Y-2.61 Insider Trans0.04% Shs Float12.74M Perf Month-8.04%
Income-218.80M PEG- EPS next Q-0.66 Inst Own64.20% Short Float0.91% Perf Quarter-22.97%
Sales- P/S- EPS this Y13.40% Inst Trans9.36% Short Ratio2.44 Perf Half Y-50.39%
Book/sh2.65 P/B1.90 EPS next Y93.20% ROA-185.30% Target Price22.80 Perf Year-67.63%
Cash/sh11.01 P/C0.46 EPS next 5Y- ROE- 52W Range4.30 - 47.82 Perf YTD-6.68%
Dividend- P/FCF- EPS past 5Y37.50% ROI- 52W High-89.27% Beta1.44
Dividend %- Quick Ratio28.60 Sales past 5Y- Gross Margin- 52W Low19.30% ATR0.45
Employees20 Current Ratio28.60 Sales Q/Q- Oper. Margin- RSI (14)46.98 Volatility8.49% 9.15%
OptionableYes Debt/Eq0.00 EPS Q/Q81.70% Profit Margin- Rel Volume0.19 Prev Close5.03
ShortableYes LT Debt/Eq0.00 EarningsNov 10 BMO Payout- Avg Volume47.37K Price5.13
Recom1.20 SMA20-2.30% SMA50-12.57% SMA200-44.92% Volume498 Change1.99%
Nov-10-21 08:00AM  
Nov-09-21 08:00AM  
Nov-05-21 08:00AM  
Oct-27-21 08:00AM  
Oct-21-21 08:00AM  
Oct-18-21 08:00AM  
Oct-12-21 08:00AM  
Oct-03-21 09:52PM  
Sep-10-21 08:00AM  
Astria Therapeutics, Inc., a biopharmaceutical company, engages in developing therapies for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-021, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development stage for the treatment of hereditary angioedema, a rare genetic disorder causing swelling in the face, limbs, abdomen, and airway. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Komjathy AndrewChief Commercial OfficerNov 19Buy6.70100670100Nov 23 04:12 PM